Follow
Gail Carson
Gail Carson
ISARIC, GloPID R, GOARN, University of Oxford
Verified email at ndm.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
bmj 369, 2020
33032020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ...
bmj 370, 2020
9742020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ...
British Medical Journal 2020, 2020
9742020
Characterising long term Covid-19: a living systematic review
M Michelen, V Cheng, L Manoharan, N Elkheir, D Dagens, C Hastie, ...
MedRxiv, 2020.12. 08.20246025, 2021
741*2021
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ...
bmj 370, 2020
6872020
Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study
O Swann, K Holden, L Turtle, L Pollock, C Fairfield, T Drake, S Seth, ...
687*2020
Characterising Long Covid: a living systematic review
M Michelen, L Manoharan, N Elkheir, V Cheng, D Dagens, C Hastie, ...
BMJ Global Health, 2021
6682021
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
A Docherty, E Harrison, C Green, H Hardwick, R Pius, L Norman, ...
4292020
ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
BMJ 369, m1985, 2020
3822020
Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia
YM Arabi, AH Hajeer, T Luke, K Raviprakash, H Balkhy, S Johani, ...
Emerging infectious diseases 22 (9), 1554, 2016
3142016
Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study
IM Osmanov, E Spiridonova, P Bobkova, A Gamirova, A Shikhaleva, ...
medRxiv, 2021
296*2021
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre …
CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ...
The Lancet Microbe, 2021
2752021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ...
medRxiv, 2021
2632021
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Y Arabi, H Balkhy, AH Hajeer, A Bouchama, FG Hayden, A Al-Omari, ...
Springerplus 4 (1), 1-8, 2015
2492015
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ...
The Lancet Respiratory Medicine 9 (4), 349-359, 2021
2052021
Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial
J Dunning, F Sahr, A Rojek, F Gannon, G Carson, B Idriss, T Massaquoi, ...
PLoS medicine 13 (4), e1001997, 2016
1912016
Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID‐19
D Munblit, P Bobkova, E Spiridonova, A Shikhaleva, A Gamirova, ...
Clinical & Experimental Allergy, 2021
1612021
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the …
CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ...
The lancet Respiratory medicine, 2021
1602021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ...
The Lancet 398 (10296), 223-237, 2021
1372021
Experimental treatment of Ebola virus disease with brincidofovir
J Dunning, SB Kennedy, A Antierens, J Whitehead, I Ciglenecki, ...
PloS one 11 (9), e0162199, 2016
1012016
The system can't perform the operation now. Try again later.
Articles 1–20